1. MARKETS
  2. SECTOR : BANKING AND FINANCE
  3. INDUSTRY : FINANCIAL CONGLOMERATES
  4. CITIUS ONCOLOGY INC.

Citius Oncology Inc.

XNAS: CTOR

Download real time

0.61 -0.01 (-1.61%)

New 52W Low in past week

49,262 XNAS Volume

XNAS 20 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
2S
11W
5O
0T
43.6

Market Cap

Below industry Median
-

PE TTM

-

PEG TTM

1.1

Price to Book

Below industry Median
0.6

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Citius Oncology Inc. is on 31 Mar 2025 for the purpose of Citius Oncology Inc Annual Report for 2024 See details


Insider Trading disclosures for Citius Oncology Inc.

The latest disclosure was made by Robert J. Smith in Citius Oncology Inc. where a trade of 125,000 Stock Option (Right to Buy) done was reported to US exchanges on Dec. 12, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Robert J. Smith Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2024 125,000 125,000 - - Stock Option (Right to Buy)
Myron Czuczman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2024 400,000 400,000 - - Stock Option (Right to Buy)
Jaime Bartushak Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2024 400,000 400,000 - - Stock Option (Right to Buy)
Eugene Holuka Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2024 125,000 125,000 - - Stock Option (Right to Buy)
Carol Webb Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2024 125,000 125,000 - - Stock Option (Right to Buy)
Suren G. Dutia Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2024 125,000 125,000 - - Stock Option (Right to Buy)
Joel D. Mayersohn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2024 250,000 250,000 - - Stock Option (Right to Buy)
Leonard L. Mazur Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2024 800,000 800,000 - - Stock Option (Right to Buy)
Myron Z. Holubiak Director, Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2024 300,000 300,000 - - Stock Option (Right to Buy)
Myron Z. Holubiak Director, Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2024 50,000 50,000 - - Stock Option (Right to Buy)
Dennis M. McGrath Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2024 125,000 125,000 - - Stock Option (Right to Buy)
Myron Czuczman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 1,400,000 1,400,000 - - Stock Option (Right to Buy)
Dennis M. McGrath Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 150,000 150,000 - - Stock Option (Right to Buy)
Jaime Bartushak Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 1,400,000 1,400,000 - - Stock Option (Right to Buy)
Leonard L. Mazur Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 3,700,000 3,700,000 - - Stock Option (Right to Buy)
Myron Z. Holubiak Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 1,500,000 1,500,000 - - Stock Option (Right to Buy)
Eugene Holuka Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 150,000 150,000 - - Stock Option (Right to Buy)
Myron Czuczman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 466,667 466,667 - - Stock Option (Right to Buy)
Jaime Bartushak Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 466,667 466,667 - - Stock Option (Right to Buy)
Carol Webb Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 150,000 150,000 - - Stock Option (Right to Buy)
Suren G. Dutia Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 150,000 150,000 - - Stock Option (Right to Buy)
Leonard L. Mazur Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 1,233,333 1,233,333 - - Stock Option (Right to Buy)
Myron Z. Holubiak Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 500,000 500,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters